Key result
Preprocedural TEE reveals LAA thrombus in ~2% of AF patients despite compliant oral anticoagulation.
Why the study?
Guidelines consider 4 weeks of uninterrupted OAC sufficient to avoid TEE, but some AF patients exhibit persistent LAA thrombus despite compliance.
What are the characteristics and management outcomes of patients with persistent LAA thrombus despite compliance with oral anticoagulation?
Observational (n=3,653)
What are the characteristics and management outcomes of patients with persistent LAA thrombus despite compliance with oral anticoagulation?
A small but clinically significant proportion of high-risk AF patients develop LAA thrombus despite compliant OAC use, challenging the guideline assumption that 4 weeks of OAC universally obviates the need for preprocedural TEE.
Answers are grounded in this paper and cite their sources.
May support preprocedural TEE despite OAC compliance; leaves open optimal management of persistent LAA thrombus.
OBJECTIVES: Assess the characteristics and management of patients with LAA thrombus despite compliance with oral anticoagulation (OAC). BACKGROUND: Atrial fibrillation guidelines consider 4 weeks of uninterrupted OAC sufficient to avoid transesophageal echocardiography to rule out left atrial appendage thrombus. However, some patients may exhibit persistent thrombus despite compliance with OAC. METHODS: Clinical history, management, and outcomes were reviewed for patients with LAA thrombus on preprocedural TEE presenting for an AF related procedure between 2021 and 2024. RESULTS: Sixty-five (1.8%) of 3653 preprocedural TEEs exhibited LAA thrombus. OAC compliance of at least 4 week was documented in 39 (60%) of these patients, including Apixaban 64%, Rivaroxaban 23%, Warfarin 8%, Dabigatran 5%. Two of these patients (3%) experienced an embolic event and 8 (12%) died during the follow up period. Resolution of LAA thrombus was documented in 12/32 patients, 6 who switched to Dabigatran, 2 to Eliquis, 1 to Warfarin, and 3 remained on Eliquis. LAA-occlusion was successfully performed in seven patients with persistent LAA thrombus. CHADS-VASc 3 or greater, HFrEF, or valvular AF were present in 37/39 of these patients. CONCLUSION: For 3653 patients who underwent Preprocedural TEE, 39 exhibited LAA thrombus despite compliance with OAC. Switching OAC or maintaining the same agent for longer period of time resolved the thrombus in 31% of cases. LAA-O was effective in cases where the thrombus did not resolve. Patients with non-valvular AF, compliance with OAC > 4 weeks, CHADS-VASc ≤ 2, and normal EF exhibited the lowest probability for not having a thrombus on TEE.
No takes yet. Share an insight, caveat, or question.
Kushnir et al. (2025) conducted an observational in Atrial Fibrillation (n=3,653). Oral anticoagulation was evaluated on Presence of LAA thrombus on preprocedural TEE. Preprocedural TEE revealed LAA thrombus in 1.8% (65/3653) of patients presenting for an AF-related procedure, including 39 patients who were compliant with oral anticoagulation for ≥4 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: